throbber
6/21/2017
`
`Restasis commercial among most memorable ads of 2013 ­ PMLiVE
`
`Restasis commercial among most memorable ads of 2013
`TV spot for Allergan’s eye drug among top 10 in Nielsen ratings
`
`The commercial for Allergan's eye drug Restasis was among the top 10 most memorable
`new TV ads in the US in 2013.
`
`In ninth place, Restasis (cyclosporine) was the only pharmaceutical brand in the Nielsen­
`compiled top 10, which included established consumer brands such as Wal­Mart, Volkswagen
`and Bud Lite.
`
`Stating that the variety of ways in which the public consumes media is “exploding”, Nielsen said
`that it wanted to understand why “some ads captivate viewers while thousands of others are
`readily disregarded". The top 10 was compiled in order to gain insight into this.
`
`Among the findings was that “enhancing the entertainment value of ads is a key way to boost
`memorability and branding”, global information and measurement company Nielsen said.
`
`“Marketers can achieve this through any combination of: telling a story that viewers can relate
`to; creating a connection through humour or emotion; or incorporating attention­grabbing sights
`and sounds,” Nielsen said in a statement.
`
`Created by Beacon Healthcare Communications, the Restasis campaign has been on TV,
`supported by print, digital, and collateral materials, since it launched in April 2013.
`
`The TV commercial features a Restasis patient discussing the drug with her doctor after
`experiencing the effects of chronic dry eye in various social environments.
`
`Notably, the commercial was the most memorable new TV spot among women aged 13 and
`over.
`
`The commercial is part of the 'Your Eyes' campaign, which promotes Restasis as the only
`prescription medicine designed to help increase the eyes' natural ability to produce tears.
`
`The drug is among eyecare specialist Allergan's biggest­selling products, with the company
`expecting revenues between $900m and $920m for 2013. 
`
`Speaking to PMLIVE, an Allergan spokesperson said: “The success of the campaign can
`primarily be attributed to the fact that the team took a deeper dive into the patient's journey and
`
`http://www.pmlive.com/pharma_news/restasis_ad_among_most_memorable_of_2013_531999
`
`1/2
`
`MYLAN - EXHIBIT 1110
`Mylan Pharmaceuticals Inc. et al. v. Allergan, Inc. - IPR2016-01127, -01128, -01129, -01130, -01131, & -01132
`
`

`

`Restasis commercial among most memorable ads of 2013 ­ PMLiVE
`6/21/2017
`experience, bringing to life the moment when a patient realises she doesn't just have dry eyes,
`she has a disease called chronic dry eye.”
`
`View the Restasis commercial on YouTube
`
`0 Comments
`
`PMlive
`
` Recommend
`
`
`
` Share⤤
`
`Start the discussion…
`
`LOG IN WITH
`
`Login1
`
`Sort by Best
`
`OR SIGN UP WITH DISQUS 
`
`?
`
`Name
`
`Be the first to comment.
`
`ALSO ON PMLIVE
`NICE's rejection of Imbruvica 'reveals
`flaws in appraisal …
`1 comment • a year ago•
`Richard Phillips — It is inevitable that
`cancer drugs that are highly­priced will …
`Pharma ramps up its use of Instagram
`1 comment • 8 months ago•
`Campfire Copywriting — I have never really
`deemed Instagram as being good for …
`
`Pharma perspectives (2)
`1 comment • 2 years ago•
`Nina Buckley — Great thoughts Samuel
`particularly your last point on digital as a
`channel …
`Why culture is too often the missing link
`in …
`1 comment • 8 months ago•
`Rauf Mirza — Hello AbigailPleased to note
`this article on culture and health. …
`
`✉
`
`Subscribe
`
`d
`
`Add Disqus to your siteAdd DisqusAdd
`
`Privacy
`
`🔒
`
`http://www.pmlive.com/pharma_news/restasis_ad_among_most_memorable_of_2013_531999
`
`2/2
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket